RPG Life Sciences Q1 Results: With a 22% increase in Q1 earnings, RPG Life Sciences achieves a 52-week high

On July 31, RPG Life Sciences' shares reached a 52-week high after the company's net profit for the June quarter increased by 22% over the same period last year to Rs 22 crore.

The revenue from operations for the first quarter of FY24 at RPG Life Sciences increased by 15% YoY to Rs 148 crore from Rs 129 crore reported in the first quarter of FY23.

EBITDA (Earnings-before-interest-taxes-depreciation and amortization) for the first quarter of FY24 was Rs 34 crore, up 17% year over year from Rs 29.1 crore recorded in the first quarter of FY23. The EBITDA margins slightly increased by 50 basis points to 23% in the quarter under review.

Pharmaceutical product manufacture and marketing are the main businesses of RPG Life Sciences. The business offers a variety of formulations and active pharmaceutical ingredients (APIs) and works in a number of therapeutic areas. Its activities include pharmaceutical product development, production, and distribution. RPG Life Sciences runs its business from two manufacturing sites in Gujarat and one API facility in Navi Mumbai.

Source: Media Reports

Top stories
Company

Delta Corp Q1 PAT Declines 68% YoY to Rs 22 crore in FY25

4 mins read . 13 Jul 2024 . 09:30 AM

Company

Zydus Life Gets USFDA Nod for Heart Failure Drug

3 mins read . 13 Jul 2024 . 09:23 AM

Company

RVNL Spurts 10% on Bagging Multiple Orders Worth Rs 390 Cr

4 mins read . 13 Jul 2024 . 09:18 AM

Related Blogs
blog-logo

Share Market

blog-logo

12 mins read . 12 Jul 2024

Ritesh Agarwal: The OYO Founder’s Success Story

  • 0 people read
blog-logo

Share Market

blog-logo

15 mins read . 08 Jul 2024

Best Oil & Gas Stocks in India

  • 0 people read
Kickstart your equities journey today You've got this
By submitting this I agree to the terms & conditions